Last reviewed · How we verify

NCT04571307

Cryotherapy in Breast B3 Lesions

Status unknown NA Last updated 5 September 2021
What this trial tests

NA trial testing cryotherapy in Breast Disease in 12 participants. Status unknown.

Timeline
15 September 2021
Primary endpoint
15 October 2022
15 October 2022

Quick facts

Lead sponsorKK Women's and Children's Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment12
Start date15 September 2021
Primary completion15 October 2022
Estimated completion15 October 2022
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

KK Women's and Children's Hospital

Who can join

Adults 21 to 75, female only, with Breast Disease or Phyllodes Breast Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the feasibility of cryotherapy for B3 fibroepithelial lesions

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of cryotherapy

Trials testing the same drug.

Other recruiting trials for Breast Disease

Currently open trials in the same condition.

Other KK Women's and Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04571307.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing